Renaissance Technologies - REPLIGEN CORP ownership

REPLIGEN CORP's ticker is RGEN and the CUSIP is 759916109. A total of 183 filers reported holding REPLIGEN CORP in Q3 2016. The put-call ratio across all filers is 2.58 and the average weighting 0.1%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of REPLIGEN CORP
ValueSharesWeighting
Q3 2022$3,539,000
-91.3%
18,912
-92.5%
0.01%
-89.6%
Q2 2022$40,879,000
-1.6%
251,716
+14.0%
0.05%
-2.0%
Q1 2022$41,533,000
-11.3%
220,816
+25.0%
0.05%
-15.5%
Q4 2021$46,801,000
-17.5%
176,716
-9.9%
0.06%
-20.5%
Q3 2021$56,703,000
-20.3%
196,212
-44.9%
0.07%
-18.0%
Q2 2021$71,108,000
-20.8%
356,216
-22.9%
0.09%
-20.5%
Q1 2021$89,820,000
-29.7%
462,012
-30.7%
0.11%
-19.4%
Q4 2020$127,826,000
-3.1%
667,044
-25.4%
0.14%
+5.3%
Q3 2020$131,950,000
+57.4%
894,337
+31.9%
0.13%
+83.3%
Q2 2020$83,812,000
+129.2%
678,033
+79.0%
0.07%
+100.0%
Q1 2020$36,563,000
+61.8%
378,733
+55.0%
0.04%
+111.8%
Q4 2019$22,601,000
+28.0%
244,332
+6.1%
0.02%
+13.3%
Q3 2019$17,662,000
+218.1%
230,304
+256.5%
0.02%
+200.0%
Q2 2019$5,552,000
-38.2%
64,600
-57.5%
0.01%
-37.5%
Q1 2019$8,980,000
+63.6%
152,004
+46.0%
0.01%
+33.3%
Q4 2018$5,490,000
+220.7%
104,104
+120.6%
0.01%
+200.0%
Q4 2017$1,712,000
-72.0%
47,200
-70.4%
0.00%
-71.4%
Q3 2017$6,112,000
-50.7%
159,500
-46.7%
0.01%
-56.2%
Q2 2017$12,407,000
-43.9%
299,400
-52.4%
0.02%
-48.4%
Q1 2017$22,120,000
-19.5%
628,400
-29.5%
0.03%
-27.9%
Q4 2016$27,479,000
-15.5%
891,600
-17.3%
0.04%
-25.9%
Q3 2016$32,536,000
+5.7%
1,077,700
-4.2%
0.06%
-1.7%
Q2 2016$30,775,000
+16.8%
1,124,804
+14.5%
0.06%
+18.0%
Q1 2016$26,348,000
+19.1%
982,404
+25.6%
0.05%
+4.2%
Q4 2015$22,126,000
-9.2%
782,104
-10.6%
0.05%
-17.2%
Q3 2015$24,363,000
-37.9%
874,790
-7.9%
0.06%
-34.8%
Q2 2015$39,211,000
+50.1%
950,104
+10.5%
0.09%
+58.9%
Q1 2015$26,115,000
+90.0%
860,165
+23.9%
0.06%
+69.7%
Q4 2014$13,747,000
-19.3%
694,304
-18.8%
0.03%
-29.8%
Q3 2014$17,033,000
+5.7%
855,504
+21.0%
0.05%
+23.7%
Q2 2014$16,117,000
+168.9%
707,200
+51.8%
0.04%
+171.4%
Q1 2014$5,993,000
-22.0%
465,993
-17.3%
0.01%
-22.2%
Q4 2013$7,685,000
+98.5%
563,400
+61.4%
0.02%
+100.0%
Q3 2013$3,872,000
+60.8%
349,100
+19.5%
0.01%
+50.0%
Q2 2013$2,408,000292,2000.01%
Other shareholders
REPLIGEN CORP shareholders Q3 2016
NameSharesValueWeighting ↓
12 West Capital Management LP 1,021,641$295,244,00013.47%
Ally Bridge Group (NY) LLC 70,000$20,229,0005.95%
Miura Global Management 85,000$24,564,0003.81%
Conestoga Capital Advisors, LLC 871,390$251,823,0003.48%
Ranger Investment Management 187,723$54,250,0002.90%
AWM Investment Company, Inc. 100,000$28,899,0002.84%
Brown Capital Management 1,017,477$294,041,0002.41%
Stephens Investment Management Group LLC 558,287$161,339,0002.19%
Yorktown Management & Research Co Inc 10,050$2,904,0002.18%
SV Health Investors, LLC 14,541$4,203,0002.06%
View complete list of REPLIGEN CORP shareholders